Preoperative gemcitabine based chemoradiotherapy in locally advanced nonmetastatic pancreatic adenocarcinoma

被引:0
|
作者
Maximous, D. [1 ]
Abdel-Wanis, M. E. [1 ]
Aboziada, M. A. [1 ]
El-Sayed, M. I. [1 ]
Abd-Elsayed, A. A. [1 ]
机构
[1] S Egypt Canc Inst, Assiut, Egypt
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15677
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function
    Tomimaru, Yoshito
    Eguchi, Hidetoshi
    Iwagami, Yoshifumi
    Akita, Hirofumi
    Noda, Takehiro
    Gotoh, Kunihito
    Kobayashi, Shogo
    Nagano, Hiroaki
    Mori, Masaki
    Doki, Yuichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 537 - 545
  • [22] Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.
    Nio, K.
    Ueno, H.
    Okusaka, T.
    Morizane, C.
    Hagihara, A.
    Kondo, S.
    Mayahara, H.
    Ito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Wang, Bu-Hai
    Cao, Wen-Miao
    Yu, Jie
    Wang, Xiao-Lei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2129 - 2132
  • [24] Gemcitabine/nabpaclitaxel efficacy in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma
    Michalaki, V.
    Poydorou, A.
    Frangulidis, G.
    Vezakis, A.
    Karvouni, E.
    Papadimitriou, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 44 - 44
  • [25] Chemoradiotherapy for locally advanced pancreatic cancer
    Diener, Markus K.
    Combs, Stephanie E.
    Buechler, Markus W.
    LANCET ONCOLOGY, 2013, 14 (04): : 269 - 270
  • [26] Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer
    Park, Joo Kyung
    Ryu, Ji Kon
    Lee, Jun Kyu
    Yoon, Won Jae
    Lee, Sang Hyub
    Kim, Yong-Tae
    Yoon, Yong Bum
    PANCREAS, 2006, 33 (04) : 397 - 402
  • [27] Predictors of Tumor Response and Survival After Preoperative Chemoradiotherapy for Locally Advanced Rectal Adenocarcinoma
    Silva-Martinez, R.
    Ramirez-Ramirez, M.
    Gutierrez de la Barrera, M.
    Luna-Perez, P.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S87 - S87
  • [28] Hypofractionated Chemoradiation Therapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally-Advanced Pancreatic Cancer
    Romeo, A.
    Parisi, E.
    Passardi, A.
    Bellia, S.
    Arpa, D.
    Ghigi, G.
    Neri, E.
    Sarnelli, A.
    Tesei, A.
    Polico, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S307 - S307
  • [29] A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer
    Mukherjee, S.
    Hurt, C.
    Griffiths, G.
    Crosby, T.
    Staffurth, J.
    Bridges, S.
    Bridgewater, J. A.
    Mcdonald, A.
    Falk, S.
    Maughan, T. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] Molecular markers as predictors of tumor response to preoperative chemoradiotherapy in locally advanced rectal adenocarcinoma
    Rodriguez-Ramirez, SE
    Alvarado, I
    Labastida, S
    Luna, P
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S117 - S117